Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPsychiatry/Behavioral Healthlucet Psychological Neuropsych Testing Coverage | …
    Ask Trek AI about this page
    CurrentlucetPolicy 20.5.004

    Psychological and Neuropsychological Testing Criteria

    Customize your policy alerts

    Sign up for lucet Policy 20.5.004 alerts

    Get alerted when Policy 20.5.004 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity, limitations, and expectations for psychological and neuropsychological testing for members when tests inform diagnosis, prognosis, or treatment planning; applies to providers requesting/performing testing under lucet benefit plans.

    Policy Summary
    Payerlucet
    PolicyPsychological and Neuropsychological Testing Criteria
    Policy CodePolicy 20.5.004
    Key ActionObtain a face-to-face diagnostic assessment and submit a comprehensive testing report with tests used, scores, and an in‑depth summary.
    Change TypeCriteria expanded & references added (2024–2025)
    Effective DateJan 1, 2023
    Last ReviewSep 1, 2025
    Next Review Date
    SourceLink
    POLICY UPDATE CHANGES

    Added 2 references and updated summary of evidence and description of treatment.

    Added criteria for psychological testing and neuropsychological testing, limitations of coverage, and expectations of treatment; updated summary of evidence.

    9Psychological indications
    8Neuropsych indications
    10Coverage limitations

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    9
    Care expectations

    Coverage Criteria — Psychological & Neuropsychological Testing

    Medical necessity criteria

    Covered when ONE OR MORE of the following indications are met:

    Psychological testing indications: Assess the presence, severity, or functional impairment of a psychological disorder to determine psychiatric diagnosis, including differentiation among disorders with similar presentations; assess mental or behavioral factors impacting disease management (including pre-surgical evaluation, assessment of ability to comply with medical interventions, and assessment in patients with chronic pain); assess specific psychological bases underlying functional complaints or disability; assess psychological barriers and strengths to aid treatment planning (treatment selection, prognosis, reasons for poor response); assess risk factors for harm to self or others; perform symptom assessment for treatment selection or to evaluate treatment effectiveness; corroborate or refute impressions from non-standardized interactions when malingering or denial is suspected; assess attention, concentration, and other cognitive deficits that impede functional adjustment; measure cognitive or functional deficits in children and adolescents when there is an inability to develop expected knowledge, skills, or abilities required for adaptation.

    Derived from section A items 1-9

    Neuropsychological testing indications: Assess cognitive or behavioral deficits related to known or suspected CNS impairment, trauma, or neuropsychiatric disorders when useful for diagnosis, prognosis, or treatment planning; establish a treatment plan by measuring functional abilities/impairments in individuals with known or suspected CNS or neuropsychiatric disorders; determine the potential impact of substances or treatments that may cause cognitive impairment (e.g., radiation, chemotherapy, prescribed or illicit drugs, toxins) or measure improvement in cognitive function for treatment planning; conduct pre-surgical or treatment-related measurement of cognitive function to determine safety of procedures that may affect brain function (e.g., DBS, tumor resection, epilepsy surgery, transplants) or that may significantly alter functional status; determine whether a medical condition impairs the patient’s ability to comprehend and participate effectively in treatment regimens or to function consistent with pre-injury/pre-illness levels; design, administer, and/or monitor outcomes of cognitive rehabilitation interventions; measure cognitive or functional deficits in children and adolescents with failure to attain expected developmental skills; evaluate primary symptoms of impaired attention and concentration occurring in many medical and psychiatric conditions.

    Derived from section B items 1-8 and section B items 4-8

    Psychological and neuropsychological testing is excluded when the patient is neurologically, cognitively, or psychologically unable to participate meaningfully in the testing process. Coverage is also excluded when there is no reasonable expectation that the patient will benefit from therapeutic or care options (i.e., testing will not inform medical or psychological management). Routine use of tests as a population screening tool without a clinical justification is excluded, as are tests administered for purely educational, vocational, or other non-clinical purposes that do not inform medical or health management.

    Testing that consists exclusively of self-administered, self-created, or self-scored inventories, or that is comprised solely of screening instruments (for example, brief cognitive screens such as the Folstein Mini‑Mental State Examination), is considered not reasonable and necessary and is excluded. Also excluded is testing or repeat testing that will not influence medical or behavioral management decisions (for example, repeat testing requested by a patient without clinical justification) and testing administered while the patient is acutely impaired by substances.

    Referenced Coding Guidance

    Referenced coding guidancemixed
    No codes listed

    Provider Actions, Documentation & Exceptions

    Note

    Exceptions and resources — CMO approval required

    Exceptions to this medical policy must be approved by the Chief Medical Officer or their designee. Related resources include the Psychological‑Neuropsychological Testing (PNT) WebPass Guide and state-specific guides listed under GUIDES / HANDOUTS; a Request for Psychological/Neuropsychological Testing form is available for submissions.

    • Exceptions require approval by the Chief Medical Officer or designee.
    • See PNT WebPass Guide and state-specific testing guides for request processes.
    • Use the Request for Psychological/Neuropsychological Testing form when submitting requests.
    Prior Authorization

    Provider actions — authorization and routing

    Submit requests using the Request for Psychological/Neuropsychological Testing form and ensure authorization routing follows the payer's WebPass/guide instructions; testing must meet the medical necessity criteria in the policy and be ordered by a qualified provider.

    Definitions

    inv-10: Psychological testing — definition and key points
    DefinitionAdministration, interpretation, and scoring of medically accepted standardized tests to evaluate functional strengths, psychopathology, psychodynamics, mental health risks, insight, motivation, and other factors influencing treatment and prognosis.
    RoleOne component of a comprehensive psychological assessment used to inform diagnosis, prognosis, and treatment planning.
    Domains AssessedFunctional strengths, psychopathology, psychodynamics, risk factors, insight, motivation, and treatment‑relevant factors.
    When to useWhen testing results will meaningfully inform diagnosis, risk assessment, or treatment decisions rather than for routine screening or nonclinical purposes.
    inv-11: Neuropsychological testing — definition and key points
    Definition

    Background

    Psychological testing is used to evaluate functional strengths, psychopathology, psychodynamics, risk, insight, motivation, and other factors that influence diagnosis, treatment planning, prognosis, and the delivery of care. Neuropsychological testing is performed to assess cognitive and neurobehavioral functioning in patients with known or suspected neurological, medical, or developmental conditions (for example, brain injury, neurodegenerative disease, autism spectrum disorder, or learning disorders) to inform diagnosis, establish baseline or treatment-related cognitive status, guide rehabilitation, and support clinical decision-making.

    Document History & Revisions

    2025-09revisionLatest

    Added 2 references, removed 1 reference, updated the summary of evidence, and added a description of treatment.

    2024-09revision

    Expanded criteria by adding psychological and neuropsychological testing sections, added limitations of coverage and expectations of treatment, and updated the summary of evidence with reference updates.

    2023-01review
    Policy Summary
    Payerlucet
    PolicyPsychological and Neuropsychological Testing Criteria
    Policy CodePolicy 20.5.004
    Key ActionObtain a face-to-face diagnostic assessment and submit a comprehensive testing report with tests used, scores, and an in‑depth summary.
    Change TypeCriteria expanded & references added (2024–2025)
    Effective DateJan 1, 2023
    Last ReviewSep 1, 2025
    Next Review Date
    SourceLink
    On This Page
    Coverage Criteria — Psychological & Neuropsychological TestingReferenced Coding GuidanceProvider Actions, Documentation & ExceptionsDefinitionsBackgroundDocument History & Revisions
    • Complete an initial face-to-face diagnostic assessment before requesting testing.
    • Use the standardized Request for Psychological/Neuropsychological Testing form for authorization.
    • Ensure the requested battery and indications align with the policy's medical necessity criteria.
    Documentation Required

    Required documentation and reporting

    An initial face-to-face complete diagnostic assessment is required prior to testing; at completion produce a comprehensive report that includes the tests administered, scores, and an in‑depth summary of findings.

    • Document the initial face-to-face diagnostic assessment that identifies specific diagnostic/clinical questions.
    • Final report must list tests used, raw/standard scores, and an in‑depth interpretation tying results to management.
    • Retain and submit the Request for Psychological/Neuropsychological Testing form when applicable.
    Denial Risk

    Triggers for denial / not reasonable and necessary

    Testing is not reasonable and necessary — and may be denied — when it is used as routine screening without clinical justification, administered for non‑clinical (educational/vocational) purposes, comprised exclusively of self‑administered or screening instruments, when the patient cannot participate meaningfully, when testing will not affect management, when the patient is under the influence of substances, or during acute delirium/psychosis.

    • Routine population screening or tests lacking a medical/psychological rationale.
    • Exclusively self‑administered, self‑scored, or screening-only batteries (e.g., Folstein MMSE).
    • Patient unable to participate meaningfully, under substance influence, or experiencing acute delirium/psychosis.
    • Repeat testing requested without clinical justification or when prior diagnosis makes testing irrelevant to management.
    Tests requested for patients with a history of psychological, neurological, or medical disorders known to impact cognitive or neurobehavioral functioning.
    Common indicationsEvaluation for autism spectrum disorder, intellectual disabilities, learning disorders, brain injury, neurodegenerative diseases, and other neurologic conditions.
    PurposeAssess cognitive and neurobehavioral functioning to inform diagnosis, prognosis, and treatment planning (including rehabilitation and pre‑surgical planning).
    ScopeUsed when there is evidence suggesting neurological problems that could affect cognition or behavior, and when results will influence clinical management.

    Initial review/new policy entry recorded.